https://m2.mtmt.hu/ hun 2026-09-21 04:36 JournalArticle 35635297 APPROVED true Department of Pulmonology, Semmelweis University, Budapest, Hungary Centre for Translational Medicine, Semmelweis University, Budapest, Hungary Department of Anesthesiology and Intensive Therapy, Semmelweis University, Budapest, Hungary Department of Anesthesiology and Intensive Therapy, Poznan University of Medical Sciences, Poznan, Poland Department of Cardiology, Central Hospital of Northern Pest - Military Hospital, Budapest, Hungary Heart and Vascular Center, Semmelweis University, Budapest, Hungary Institute of Pancreatic Diseases, Semmelweis University, Budapest, Hungary Institute for Translational Medicine, Medical School, University of Pécs, Pécs, Hungary Export Date: 16 July 2025; Cited By: 0; Correspondence Address: V. Müller; Department of Pulmonology, Semmelweis University, Budapest, Tomo utca 25-29, 1083, Hungary; email: muller.veronika@semmelweis.hu 0 false 2026-09-20T20:10:26.867+0000 2026-05-29T10:19:44.420+0000 2024-12-12T14:57:15.416+0000 true 10085578 Fi Tamás /api/admin/10085578 Admin Fi Tamás (SE_AOK_Pulmonologia_Admin5_FT, admin) true 2026-07-19T11:30:45.169+0000 true false true 24 24 /api/publicationtype/24 PublicationType Folyóiratcikk 1 true 24 JournalArticle true 1134514 Survey paper true 24 24 /api/publicationtype/24 PublicationType Folyóiratcikk 1 true 24 JournalArticle /api/subtype/1134514 Összefoglaló cikk SubType Összefoglaló cikk (Folyóiratcikk) 102 true 1134514 true 1 /api/category/1 Category Tudományos true 1 Matics, Zsombor true true /api/journal/20068711 REVIEWED ECLINICALMEDICINE 2589-5370 2589-5370 true false false 20068711 true 2589-5370 2589-5370 Journal FOREIGN 79 102966 102966 12 2025 true true 2024 true true true false true false GOLD 2026-09-20 true https://doi.org/10.1016/j.eclinm.2024.102966 5 0 5 5 0 5 5 4 5 5 5 5 5 5 0 0 5 5 5 5 0 8 8 Folyóiratcikk Journal Article 24 5 Könyvrészlet Chapter in Book 25 0 Könyv Book 23 0 Egyéb konferenciaközlemény Conference paper 31 0 Egyéb konferenciakötet Conference proceedings 32 0 Oltalmi formák Protection forms 26 0 Disszertáció Thesis 28 0 Egyéb Miscellaneous 29 0 Alkotás Achievement 22 0 Kutatási adat Research data 33 0 Folyóiratcikk Journal Article 24 0 0 0 Könyvrészlet Chapter in Book 25 0 0 0 Könyv Book 23 0 0 0 Egyéb konferenciaközlemény Conference paper 31 0 0 0 Egyéb konferenciakötet Conference proceedings 32 0 0 0 Oltalmi formák Protection forms 26 0 0 0 Disszertáció Thesis 28 0 0 0 Egyéb Miscellaneous 29 0 0 0 Alkotás Achievement 22 0 0 0 Kutatási adat Research data 33 0 0 0 2026 0 5 5 5 5 D1 false false false false 2024-12-11T14:57:19.620+0000 Aneszteziológiai és Intenzív Terápiás Klinika (SE / AOK / K); Aneszteziológiai és Intenzív Terápiás Tanszék (SE / AOK / K); Pankreász Betegségek Intézete (SE / AOK / K); Pulmonológiai Klinika (SE / AOK / K); Transzlációs Medicina Intézet (PTE / ÁOK); Transzlációs Medicina Központ (SE / KSZE); Városmajori Szív- és Érgyógyászati Klinika (SE / AOK / K) 11 57 7 11 0 true Language 10002 /api/language/10002 Angol Angol English true 2 true PersonAuthorship 122149390 /api/authorship/122149390 Matics, Zsombor [Matics, Zsombor Zoltán (Pulmonológia), szerző] Pulmonológiai Klinika (SE / AOK / K); Transzlációs Medicina Központ (SE / KSZE) 1 0.091 true false false Author 10071336 /api/author/10071336 Matics Zsombor Zoltán (Pulmonológia) Matics Zsombor Zoltán true true Matics Zsombor true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 122149391 /api/authorship/122149391 Bardóczi, Anna [Bardóczi, Anna Boglárka (pulmonológus rezi...), szerző] Pulmonológiai Klinika (SE / AOK / K); Transzlációs Medicina Központ (SE / KSZE) 2 0.091 false false false Author 10089633 /api/author/10089633 Bardóczi Anna Boglárka (pulmonológus rezidens) Bardóczi Anna Boglárka true true Bardóczi Anna true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 122149392 /api/authorship/122149392 Galkó, Csongor [Galkó, Csongor (általános orvostu...), szerző] Pulmonológiai Klinika (SE / AOK / K) 3 0.091 false false false Author 10100441 /api/author/10100441 Galkó Csongor (általános orvostudomány) Galkó Csongor true true Galkó Csongor true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 122149393 /api/authorship/122149393 Szabó, Bence [Szabó, Bence (Biológia, paleont...), szerző] Transzlációs Medicina Központ (SE / KSZE) 4 0.091 false false false Author 10055762 /api/author/10055762 Szabó Bence (Biológia, paleontológia) Szabó Bence true 10055762 true Szabó Bence true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 122149394 /api/authorship/122149394 Gede, Noémi [Gede, Noémi (Egészségtudomány), szerző] Transzlációs Medicina Központ (SE / KSZE) 5 0.091 false false false Author 10048360 /api/author/10048360 Gede Noémi (Egészségtudomány) Gede Noémi true 10048360 true Gede Noémi true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 122149395 /api/authorship/122149395 Molnár, Zsolt [Molnár, Zsolt (Klinikai orvostud...), szerző] Transzlációs Medicina Központ (SE / KSZE); Aneszteziológiai és Intenzív Terápiás Tanszék (SE / AOK / K) 6 0.091 false false false Author 10001298 /api/author/10001298 Molnár Zsolt (Klinikai orvostudományok - aneszteziológia és intenzív terápia) Molnár Zsolt true 10001298 true Molnár Zsolt true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 122149396 /api/authorship/122149396 Duray, Gábor [Duray, Gábor Zoltán (Kardiológia), szerző] Transzlációs Medicina Központ (SE / KSZE); Városmajori Szív- és Érgyógyászati Klinika (SE / AOK / K) 7 0.091 false false false Author 10015391 /api/author/10015391 Duray Gábor Zoltán (Kardiológia) Duray Gábor Zoltán true 10015391 true Duray Gábor true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 122149397 /api/authorship/122149397 Turan, Caner [Turan, Caner (Anesthesia and In...), szerző] Aneszteziológiai és Intenzív Terápiás Klinika (SE / AOK / K); Transzlációs Medicina Központ (SE / KSZE) 8 0.091 false false false Author 10077662 /api/author/10077662 Turan Caner (Anesthesia and Intensive Care) Turan Caner true true Turan Caner true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 122149398 /api/authorship/122149398 Hegyi, Péter [Hegyi, Péter (Gasztroenterológia), szerző] Transzlációs Medicina Intézet (PTE / ÁOK); Pankreász Betegségek Intézete (SE / AOK / K); Transzlációs Medicina Központ (SE / KSZE) 9 0.091 false false false Author 10002629 /api/author/10002629 Hegyi Péter (Gasztroenterológia) Hegyi Péter true 10002629 true Hegyi Péter true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 122149399 /api/authorship/122149399 Horváth, Gábor [Horváth, Gábor (Pulmonológia), szerző] Pulmonológiai Klinika (SE / AOK / K) 10 0.091 false false false Author 10011777 /api/author/10011777 Horváth Gábor (Pulmonológia) Horváth Gábor true 10011777 true Horváth Gábor true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 122149400 /api/authorship/122149400 Müller, Veronika ✉ [Müller, Veronika (Pulmonológia), szerző] Pulmonológiai Klinika (SE / AOK / K) 11 0.091 false true true Author 10012282 /api/author/10012282 Müller Veronika (Pulmonológia) Müller Veronika true 10012282 true Müller Veronika true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PublicationIdentifier 28096644 /api/publicationidentifier/28096644 DOI: 10.1016/j.eclinm.2024.102966 PlainSource 6 /api/publicationsource/6 DOI PublicationSourceType 10001 /api/publicationsourcetype/10001 DOI true true true DOI DOI https://doi.org/@@@ true true 6 true GOLD true IDENTICAL 10.1016/j.eclinm.2024.102966 https://doi.org/10.1016/j.eclinm.2024.102966 false true PublicationIdentifier 28125547 /api/publicationidentifier/28125547 WoS: 001373919000001 PlainSource 1 /api/publicationsource/1 WoS PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true WoS WoS https://www.webofscience.com/wos/woscc/full-record/@@@ true true 1 true IDENTICAL 001373919000001 https://www.webofscience.com/wos/woscc/full-record/001373919000001 false true PublicationIdentifier 28110140 /api/publicationidentifier/28110140 Scopus: 85211017818 PlainSource 3 /api/publicationsource/3 Scopus PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true Scopus Scopus http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-@@@ true true 3 true IDENTICAL 85211017818 http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85211017818 false true PublicationIdentifier 28137987 /api/publicationidentifier/28137987 PubMed: 39720602 PlainSource 17 /api/publicationsource/17 PubMed PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true PubMed PubMed http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=@@@&dopt=Abstract true true 17 true IDENTICAL 39720602 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=39720602&dopt=Abstract true true Classification 12246 /api/classification/12246 Légzőrendszer true true Keyword 3375201 /api/keyword/3375201 [Meta-analysis] true true SjrRating 11602372 /api/sjrrating/11602372 sjr:D1 (2025) Scopus - Medicine (miscellaneous) ECLINICALMEDICINE 2589-5370 2589-5370 50 0.1 journal RatingType 10002 /api/ratingtype/10002 sjr sjr true true ClassificationExternal 2701 /api/classificationexternal/2701 Scopus - Medicine (miscellaneous) true 2701 true D1 DIRECT true true Reference 60692008 /api/reference/60692008 1. Raghu 2011: An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management., Am J Respir Crit Care Med, 183, p. 788, DOI: 10.1164/rccm.2009-040GL 1 10.1164/rccm.2009-040GL false true Reference 60692009 /api/reference/60692009 2. Naik 2010: Viral infection and aging as cofactors for the development of pulmonary fibrosis., Expert Rev Respir Med, 4, p. 759, DOI: 10.1586/ers.10.73 2 10.1586/ers.10.73 false true Reference 60692010 /api/reference/60692010 3. Marshall 1997: The pathogenesis of pulmonary fibrosis: is there a fibrosis gene?., Int J Biochem Cell Biol, 29, p. 107, DOI: 10.1016/S1357-2725(96)00141-0 3 10.1016/S1357-2725(96)00141-0 false true Reference 60692011 /api/reference/60692011 4. Petnak 2021: Impact of antifibrotic therapy on mortality and acute exacerbation in idiopathic pulmonary fibrosis: a systematic review and meta-analysis., Chest, 160, p. 1751, DOI: 10.1016/j.chest.2021.06.049 4 10.1016/j.chest.2021.06.049 false true Reference 60692012 /api/reference/60692012 5. Finnerty 2021: Efficacy of antifibrotic drugs, nintedanib and pirfenidone, in treatment of progressive pulmonary fibrosis in both idiopathic pulmonary fibrosis (IPF) and non-IPF: a systematic review and meta-analysis., BMC Pulm Med, 21, p. 411, DOI: 10.1186/s12890-021-01783-1 5 10.1186/s12890-021-01783-1 false true Reference 60692013 /api/reference/60692013 6. Jovanovic 2022: Comorbidity burden and survival in patients with idiopathic pulmonary fibrosis: the EMPIRE registry study., Respir Res, 23, p. 135, DOI: 10.1186/s12931-022-02033-6 6 10.1186/s12931-022-02033-6 false true Reference 60692014 /api/reference/60692014 7. Barczi 2019: Long-term effects and adverse events of nintedanib therapy in idiopathic pulmonary fibrosis patients with functionally advanced disease., Adv Ther, 36, p. 1221, DOI: 10.1007/s12325-019-00906-9 7 10.1007/s12325-019-00906-9 false true Reference 60692015 /api/reference/60692015 8. Tsubouchi 2023: Survival and acute exacerbation for patients with idiopathic pulmonary fibrosis (IPF) or non-IPF idiopathic interstitial pneumonias: 5-year follow-up analysis of a prospective multi-institutional patient registry., BMJ Open Respir Res, 10 8 false true Reference 60692016 /api/reference/60692016 9. Guenther 2018: The European IPF registry (eurIPFreg): baseline characteristics and survival of patients with idiopathic pulmonary fibrosis., Respir Res, 19, p. 141, DOI: 10.1186/s12931-018-0845-5 9 10.1186/s12931-018-0845-5 false true Reference 60692017 /api/reference/60692017 10. Behr 2020: Survival and course of lung function in the presence or absence of antifibrotic treatment in patients with idiopathic pulmonary fibrosis: long-term results of the INSIGHTS-IPF registry., Eur Respir J, 56, DOI: 10.1183/13993003.02279-2019 10 10.1183/13993003.02279-2019 false true Reference 60692018 /api/reference/60692018 11. Cox 2022: Incidence, prevalence and mortality of idiopathic pulmonary fibrosis in Australia., Respirology, 27, p. 209, DOI: 10.1111/resp.14194 11 10.1111/resp.14194 false true Reference 60692019 /api/reference/60692019 12. de Andrade 2023: Effect of antifibrotic therapy on survival in patients with idiopathic pulmonary fibrosis., Clin Ther, 45, p. 306, DOI: 10.1016/j.clinthera.2023.03.003 12 10.1016/j.clinthera.2023.03.003 false true Reference 60692020 /api/reference/60692020 13. Song 2011: Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome., Eur Respir J, 37, p. 356, DOI: 10.1183/09031936.00159709 13 10.1183/09031936.00159709 false true Reference 60692021 /api/reference/60692021 14. Bando 2024: Japanese guidelines for the treatment of idiopathic pulmonary fibrosis 2023:Revised edition., Respir Investig, 62, p. 402, DOI: 10.1016/j.resinv.2024.02.014 14 10.1016/j.resinv.2024.02.014 false true Reference 60692022 /api/reference/60692022 15. Kreuter 2020: Acute exacerbation of idiopathic pulmonary fibrosis: international survey and call for harmonisation., Eur Respir J, 55, DOI: 10.1183/13993003.01760-2019 15 10.1183/13993003.01760-2019 false true Reference 60692023 /api/reference/60692023 16. Judge 2012: Acute exacerbations and pulmonary hypertension in advanced idiopathic pulmonary fibrosis., Eur Respir J, 40, p. 93, DOI: 10.1183/09031936.00115511 16 10.1183/09031936.00115511 false true Reference 60692024 /api/reference/60692024 17. Bando 2022: Acute exacerbation of idiopathic pulmonary fibrosis after SARS-CoV-2 vaccination., Eur Respir J, 59, DOI: 10.1183/13993003.02806-2021 17 10.1183/13993003.02806-2021 false true Reference 60692025 /api/reference/60692025 18. Oh 2012: Smoking and idiopathic pulmonary fibrosis., Pulm Med, 2012, DOI: 10.1155/2012/808260 18 10.1155/2012/808260 false true Reference 60692026 /api/reference/60692026 19. Khor 2023: Treatable traits: a comprehensive precision medicine approach in interstitial lung disease., Eur Respir J, 62, DOI: 10.1183/13993003.00404-2023 19 10.1183/13993003.00404-2023 false true Reference 60692027 /api/reference/60692027 20. Safiri 2022: Global burden of lower respiratory infections during the last three decades., Front Public Health, 10 20 false true Reference 60692028 /api/reference/60692028 21. Pitre 2024: Prognostic factors associated with mortality in acute exacerbations of idiopathic pulmonary fibrosis: a systematic review and meta-analysis., Respir Med, 222, DOI: 10.1016/j.rmed.2023.107515 21 10.1016/j.rmed.2023.107515 false true Reference 60692029 /api/reference/60692029 22. Rangappa 2009: Outcomes of patients admitted to the intensive care unit with idiopathic pulmonary fibrosis., Crit Care Resusc, 11, p. 102 22 false true Reference 60692030 /api/reference/60692030 23. Ho 2020: Trends and seasonal variation of hospitalization and mortality of interstitial lung disease in the United States from 2006 to 2016., Respir Res, 21, p. 152, DOI: 10.1186/s12931-020-01421-0 23 10.1186/s12931-020-01421-0 false true Reference 60692031 /api/reference/60692031 24. Huapaya 2018: Risk factors for mortality and mortality rates in interstitial lung disease patients in the intensive care unit., Eur Respir Rev, 27, DOI: 10.1183/16000617.0061-2018 24 10.1183/16000617.0061-2018 false true Reference 60692032 /api/reference/60692032 25. Venkatesan 2024: GOLD COPD report: 2024 update., Lancet Respir Med, 12, p. 15, DOI: 10.1016/S2213-2600(23)00461-7 25 10.1016/S2213-2600(23)00461-7 false true Reference 60692033 /api/reference/60692033 26. Wootton 2011: Viral infection in acute exacerbation of idiopathic pulmonary fibrosis., Am J Respir Crit Care Med, 183, p. 1698, DOI: 10.1164/rccm.201010-1752OC 26 10.1164/rccm.201010-1752OC false true Reference 60692034 /api/reference/60692034 27. Page 2021: The PRISMA 2020 statement: an updated guideline for reporting systematic reviews., BMJ, 372, p. n71, DOI: 10.1136/bmj.n71 27 10.1136/bmj.n71 false true Reference 60692035 /api/reference/60692035 28. Haddaway 2022: Citationchaser: a tool for transparent and efficient forward and backward citation chasing in systematic searching., Res Synth Methods, 13, p. 533, DOI: 10.1002/jrsm.1563 28 10.1002/jrsm.1563 false true Reference 60692036 /api/reference/60692036 29. McHugh 2012: Interrater reliability: the kappa statistic., Biochem Med, 22, p. 276, DOI: 10.11613/BM.2012.031 29 10.11613/BM.2012.031 false true Reference 60692037 /api/reference/60692037 30. Viechtbauer 2021: A general workflow for complex meta-analyses with dependent effect sizes Workshop on ‘Exploring the Limits of Advanced Meta-Analysis’ 30 false true Reference 60692038 /api/reference/60692038 31. Van den Noortgate 2013: Three-level meta-analysis of dependent effect sizes., Behav Res Methods, 45, DOI: 10.3758/s13428-012-0261-6 31 10.3758/s13428-012-0261-6 false true Reference 60692039 /api/reference/60692039 32. Assink 2016: Fitting three-level meta-analytic models in R: a step-by-step tutorial., Quantitative Methods Psychol, 12, DOI: 10.20982/tqmp.12.3.p154 32 10.20982/tqmp.12.3.p154 false true Reference 60692040 /api/reference/60692040 33. Higgins 2002: Quantifying heterogeneity in a meta-analysis., Stat Med, 21, p. 1539, DOI: 10.1002/sim.1186 33 10.1002/sim.1186 false true Reference 60692041 /api/reference/60692041 34. Egger 1997: Bias in meta-analysis detected by a simple, graphical test., BMJ, 315, p. 629, DOI: 10.1136/bmj.315.7109.629 34 10.1136/bmj.315.7109.629 false true Reference 60692042 /api/reference/60692042 35. 2023: R: a language and environment for statistical computing. Vienna, Austria 35 false true Reference 60692043 /api/reference/60692043 36. Schwarzer 2023: Meta: general package for meta-analysis 36 false true Reference 60692044 /api/reference/60692044 37. Viechtbauer 2023: Metafor: meta-analysis package for R 37 false true Reference 60692045 /api/reference/60692045 38. Balduzzi S 2023: Netmeta: an R package for network meta-analysis using frequentist methods., J Stat Software, 106, p. 1 38 false true Reference 60692046 /api/reference/60692046 39. J 2023: Pairwise: rasch model parameters by pairwise algorithm 39 false true Reference 60692047 /api/reference/60692047 40. 2022: Cochrane handbook for systematic reviews of interventions 40 false true Reference 60692048 /api/reference/60692048 41. Higgins 2019: Cochrane handbook for systematic reviews of interventions. Version 6.0 41 false true Reference 60692049 /api/reference/60692049 42. Guyatt 2008: GRADE: an emerging consensus on rating quality of evidence and strength of recommendations., BMJ, 336, p. 924, DOI: 10.1136/bmj.39489.470347.AD 42 10.1136/bmj.39489.470347.AD false true Reference 60692050 /api/reference/60692050 43. Nikolakopoulou 2020: CINeMA: an approach for assessing confidence in the results of a network meta-analysis., PLoS Med, 17, p. e1003082, DOI: 10.1371/journal.pmed.1003082 43 10.1371/journal.pmed.1003082 false true Reference 60692051 /api/reference/60692051 44. Richeldi 2014: Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis., N Engl J Med, 370, p. 2071, DOI: 10.1056/NEJMoa1402584 44 10.1056/NEJMoa1402584 false true Reference 60692052 /api/reference/60692052 45. Taniguchi 2010: Pirfenidone in idiopathic pulmonary fibrosis., Eur Respir J, 35, p. 821, DOI: 10.1183/09031936.00005209 45 10.1183/09031936.00005209 false true Reference 60692053 /api/reference/60692053 46. King 2014: A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis., N Engl J Med, 370, p. 2083, DOI: 10.1056/NEJMoa1402582 46 10.1056/NEJMoa1402582 false true Reference 60692054 /api/reference/60692054 47. Noble 2011: Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials., Lancet, 377, p. 1760, DOI: 10.1016/S0140-6736(11)60405-4 47 10.1016/S0140-6736(11)60405-4 false true Reference 60692055 /api/reference/60692055 48. Richeldi 2011: Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis., N Engl J Med, 365, p. 1079, DOI: 10.1056/NEJMoa1103690 48 10.1056/NEJMoa1103690 false true Reference 60692056 /api/reference/60692056 49. Richeldi 2020: Pamrevlumab, an anti-connective tissue growth factor therapy, for idiopathic pulmonary fibrosis (PRAISE): a phase 2, randomised, double-blind, placebo-controlled trial., Lancet Respir Med, 8, p. 25, DOI: 10.1016/S2213-2600(19)30262-0 49 10.1016/S2213-2600(19)30262-0 false true Reference 60692057 /api/reference/60692057 50. Maher 2021: Phase 2 trial to assess lebrikizumab in patients with idiopathic pulmonary fibrosis., Eur Respir J, 57, DOI: 10.1183/13993003.02442-2019 50 10.1183/13993003.02442-2019 false true Reference 60692058 /api/reference/60692058 51. Raghu 2017: Efficacy of simtuzumab versus placebo in patients with idiopathic pulmonary fibrosis: a randomised, double-blind, controlled, phase 2 trial., Lancet Respir Med, 5, p. 22, DOI: 10.1016/S2213-2600(16)30421-0 51 10.1016/S2213-2600(16)30421-0 false true Reference 60692059 /api/reference/60692059 52. Martinez 2021: Effect of antimicrobial therapy on respiratory hospitalization or death in adults with idiopathic pulmonary fibrosis: the CleanUP-IPF randomized clinical trial., JAMA, 325, p. 1841, DOI: 10.1001/jama.2021.4956 52 10.1001/jama.2021.4956 false true Reference 60692060 /api/reference/60692060 53. Daniels 2010: Imatinib treatment for idiopathic pulmonary fibrosis: randomized placebo-controlled trial results., Am J Respir Crit Care Med, 181, p. 604, DOI: 10.1164/rccm.200906-0964OC 53 10.1164/rccm.200906-0964OC false true Reference 60692061 /api/reference/60692061 54. Demedts 2005: High-dose acetylcysteine in idiopathic pulmonary fibrosis., N Engl J Med, 353, p. 2229, DOI: 10.1056/NEJMoa042976 54 10.1056/NEJMoa042976 false true Reference 60692062 /api/reference/60692062 55. Malouf 2011: An investigator-driven study of everolimus in surgical lung biopsy confirmed idiopathic pulmonary fibrosis., Respirology, 16, p. 776, DOI: 10.1111/j.1440-1843.2011.01955.x 55 10.1111/j.1440-1843.2011.01955.x false true Reference 60692063 /api/reference/60692063 56. Wilson 2020: Effect of Co-trimoxazole (Trimethoprim-Sulfamethoxazole) vs placebo on death, lung transplant, or hospital admission in patients with moderate and severe idiopathic pulmonary fibrosis: the EME-TIPAC randomized clinical trial., JAMA, 324, p. 2282, DOI: 10.1001/jama.2020.22960 56 10.1001/jama.2020.22960 false true Reference 60692064 /api/reference/60692064 57. Maher 2023: Ziritaxestat, a novel autotaxin inhibitor, and lung function in idiopathic pulmonary fibrosis: the ISABELA 1 and 2 randomized clinical trials., JAMA, 329, p. 1567, DOI: 10.1001/jama.2023.5355 57 10.1001/jama.2023.5355 false true Reference 60692065 /api/reference/60692065 58. Kataoka 2023: Long-term effect of pulmonary rehabilitation in idiopathic pulmonary fibrosis: a randomised controlled trial., Thorax, 78, p. 784, DOI: 10.1136/thorax-2022-219792 58 10.1136/thorax-2022-219792 false true Reference 60692066 /api/reference/60692066 59. Parker 2018: A phase 2 randomized controlled study of tralokinumab in subjects with idiopathic pulmonary fibrosis., Am J Respir Crit Care Med, 197, p. 94, DOI: 10.1164/rccm.201704-0784OC 59 10.1164/rccm.201704-0784OC false true Reference 60692067 /api/reference/60692067 60. Raghu 2013: Macitentan for the treatment of idiopathic pulmonary fibrosis: the randomised controlled MUSIC trial., Eur Respir J, 42, p. 1622, DOI: 10.1183/09031936.00104612 60 10.1183/09031936.00104612 false true Reference 60692068 /api/reference/60692068 61. King 2011: BUILD-3: a randomized, controlled trial of bosentan in idiopathic pulmonary fibrosis., Am J Respir Crit Care Med, 184, p. 92, DOI: 10.1164/rccm.201011-1874OC 61 10.1164/rccm.201011-1874OC false true Reference 60692069 /api/reference/60692069 62. King 2009: Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial., Lancet, 374, p. 222, DOI: 10.1016/S0140-6736(09)60551-1 62 10.1016/S0140-6736(09)60551-1 false true Reference 60692070 /api/reference/60692070 63. Raghu 1991: Azathioprine combined with prednisone in the treatment of idiopathic pulmonary fibrosis: a prospective double-blind, randomized, placebo-controlled clinical trial., Am Rev Respir Dis, 144, p. 291, DOI: 10.1164/ajrccm/144.2.291 63 10.1164/ajrccm/144.2.291 false true Reference 60692071 /api/reference/60692071 64. Shulgina 2013: Treating idiopathic pulmonary fibrosis with the addition of co-trimoxazole: a randomised controlled trial., Thorax, 68, p. 155, DOI: 10.1136/thoraxjnl-2012-202403 64 10.1136/thoraxjnl-2012-202403 false true Reference 60692072 /api/reference/60692072 65. Raghu 2018: SAR156597 in idiopathic pulmonary fibrosis: a phase 2 placebo-controlled study (DRI11772)., Eur Respir J, 52, DOI: 10.1183/13993003.01130-2018 65 10.1183/13993003.01130-2018 false true Reference 60692073 /api/reference/60692073 66. Richeldi 2024: Zinpentraxin alfa for idiopathic pulmonary fibrosis: the randomized phase III STARSCAPE trial., Am J Respir Crit Care Med, 209, p. 1132, DOI: 10.1164/rccm.202401-0116OC 66 10.1164/rccm.202401-0116OC false true Reference 60692074 /api/reference/60692074 67. Raghu 2024: Pamrevlumab for idiopathic pulmonary fibrosis: the ZEPHYRUS-1 randomized clinical trial., JAMA, 332, p. 380, DOI: 10.1001/jama.2024.8693 67 10.1001/jama.2024.8693 false true Reference 60692075 /api/reference/60692075 68. Collard 2016: Acute exacerbation of idiopathic pulmonary fibrosis. An international working group report., Am J Respir Crit Care Med, 194, p. 265, DOI: 10.1164/rccm.201604-0801CI 68 10.1164/rccm.201604-0801CI false true Reference 60692076 /api/reference/60692076 69. Invernizzi 2020: Bacterial burden in the lower airways predicts disease progression in idiopathic pulmonary fibrosis and is independent of radiological disease extent., Eur Respir J, 55, DOI: 10.1183/13993003.01519-2019 69 10.1183/13993003.01519-2019 false true Reference 60692077 /api/reference/60692077 70. Mostafaei 2021: The role of viral and bacterial infections in the pathogenesis of IPF: a systematic review and meta-analysis., Respir Res, 22, p. 53, DOI: 10.1186/s12931-021-01650-x 70 10.1186/s12931-021-01650-x false true Reference 60692078 /api/reference/60692078 71. Nagy 2022: Clinical predictors of lung-function decline in systemic-sclerosis-associated interstitial lung disease patients with normal spirometry., Biomedicines, 10, DOI: 10.3390/biomedicines10092129 71 10.3390/biomedicines10092129 false true Reference 60692079 /api/reference/60692079 72. Lassenius 2020: Forced Vital Capacity (FVC) decline, mortality and healthcare resource utilization in idiopathic pulmonary fibrosis., Eur Clin Respir J, 7, DOI: 10.1080/20018525.2019.1702618 72 10.1080/20018525.2019.1702618 false true Reference 60692080 /api/reference/60692080 73. Raghu 2022: Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS/ERS/JRS/ALAT clinical practice guideline., Am J Respir Crit Care Med, 205, p. e18, DOI: 10.1164/rccm.202202-0399ST 73 10.1164/rccm.202202-0399ST false true Reference 60692081 /api/reference/60692081 74. Hayden 2015: Childhood pneumonia increases risk for chronic obstructive pulmonary disease: the COPDGene study., Respir Res, 16, p. 115, DOI: 10.1186/s12931-015-0273-8 74 10.1186/s12931-015-0273-8 false true Reference 60692082 /api/reference/60692082 75. Müller 2022: Booster vaccination decreases 28-day all-cause mortality of the elderly hospitalized due to SARS-CoV-2 delta variant., Vaccines (Basel), 10 75 false true Reference 60692083 /api/reference/60692083 76. Polivka 2023: Waning of SARS-CoV-2 vaccine effectiveness in COPD patients: lessons from the delta variant., Vaccines (Basel), 11 76 false true Reference 60692084 /api/reference/60692084 77. 2024: Adult immunization schedule by medical condition and other indication 77 false true Reference 60692085 /api/reference/60692085 78. Raghu 2018: Diagnosis of idiopathic pulmonary fibrosis. An official ATS/ERS/JRS/ALAT clinical practice guideline., Am J Respir Crit Care Med, 198, p. e44, DOI: 10.1164/rccm.201807-1255ST 78 10.1164/rccm.201807-1255ST false true Reference 60692086 /api/reference/60692086 79. Richeldi 2022: Trial of a preferential phosphodiesterase 4B inhibitor for idiopathic pulmonary fibrosis., N Engl J Med, 386, p. 2178, DOI: 10.1056/NEJMoa2201737 79 10.1056/NEJMoa2201737 false true Reference 60692087 /api/reference/60692087 80. Corte 2021: Phase 2 trial design of BMS-986278, a lysophosphatidic acid receptor 1 (LPA(1)) antagonist, in patients with idiopathic pulmonary fibrosis (IPF) or progressive fibrotic interstitial lung disease (PF-ILD)., BMJ Open Respir Res, 8 80 false true Reference 60692088 /api/reference/60692088 81. Decaris 2021: Dual inhibition of α(v)β(6) and α(v)β(1) reduces fibrogenesis in lung tissue explants from patients with IPF., Respir Res, 22, p. 265, DOI: 10.1186/s12931-021-01863-0 81 10.1186/s12931-021-01863-0 false true Reference 60692089 /api/reference/60692089 82. West 2023: Inhaled pirfenidone solution (AP01) for IPF: a randomised, open-label, dose-response trial., Thorax, 78, p. 882, DOI: 10.1136/thorax-2022-219391 82 10.1136/thorax-2022-219391 false true Reference 60692090 /api/reference/60692090 83. Doi 2023: A phase I study of TRK-250, a novel siRNA-based oligonucleotide, in patients with idiopathic pulmonary fibrosis., J Aerosol Med Pulm Drug Deliv, 36, p. 300, DOI: 10.1089/jamp.2023.0014 83 10.1089/jamp.2023.0014 false true Reference 60692091 /api/reference/60692091 84. Kalluri 2021: Patient-reported outcomes and patient-reported outcome measures in interstitial lung disease: where to go from here?., Eur Respir Rev, 30, DOI: 10.1183/16000617.0026-2021 84 10.1183/16000617.0026-2021 false true Reference 60692092 /api/reference/60692092 85. Wijsenbeek 2016: New insights on patient-reported outcome measures in idiopathic pulmonary fibrosis: only PROMises?., Curr Opin Pulm Med, 22, p. 434, DOI: 10.1097/MCP.0000000000000294 85 10.1097/MCP.0000000000000294 false true Reference 60692093 /api/reference/60692093 86. Kim 2021: Psychometric properties of patient reported outcome measures in idiopathic pulmonary fibrosis., Chron Respir Dis, 18, DOI: 10.1177/14799731211033925 86 10.1177/14799731211033925 false true /api/publication/35635297 Matics Zsombor et al. Treatable traits in idiopathic pulmonary fibrosis: focus on respiratory tract infections—a systematic review and a meta-analysis. (2025) ECLINICALMEDICINE 2589-5370 2589-5370 79<div class="JournalArticle Publication long-list"> <div class="authors"> <img title="Forrásközlemény" style="float: left" src="/frontend/resources/grid/publication-core-icon.png"> <img title="Idézőközlemény" style="float: left" src="/frontend/resources/grid/publication-citation-icon.png"> <div class="autype autype0"> <span class="author-name" mtid="10071336"><a href="/gui2/?type=authors&mode=browse&sel=10071336" target="_blank">Matics Zsombor (<span class="authorship-author-name">Matics Zsombor Zoltán</span> <span class="authorAux-mtmt"> Pulmonológia</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Klinikum">K</span>/Pulmonológiai Klinika; <span title="Semmelweis Egyetem">SE</span>/<span title="Központi Szervezeti Egységek (beleértve az Egyéb Szervezeti Egységeket)">KSZE</span>/Transzlációs Medicina Központ</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10089633"><a href="/gui2/?type=authors&mode=browse&sel=10089633" target="_blank">Bardóczi Anna (<span class="authorship-author-name">Bardóczi Anna Boglárka</span> <span class="authorAux-mtmt"> pulmonológus rezidens</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Klinikum">K</span>/Pulmonológiai Klinika; <span title="Semmelweis Egyetem">SE</span>/<span title="Központi Szervezeti Egységek (beleértve az Egyéb Szervezeti Egységeket)">KSZE</span>/Transzlációs Medicina Központ</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10100441"><a href="/gui2/?type=authors&mode=browse&sel=10100441" target="_blank">Galkó Csongor (<span class="authorship-author-name">Galkó Csongor</span> <span class="authorAux-mtmt"> általános orvostudomány</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Klinikum">K</span>/Pulmonológiai Klinika</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10055762"><a href="/gui2/?type=authors&mode=browse&sel=10055762" target="_blank">Szabó Bence (<span class="authorship-author-name">Szabó Bence</span> <span class="authorAux-mtmt"> Biológia, paleontológia</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Központi Szervezeti Egységek (beleértve az Egyéb Szervezeti Egységeket)">KSZE</span>/Transzlációs Medicina Központ</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10048360"><a href="/gui2/?type=authors&mode=browse&sel=10048360" target="_blank">Gede Noémi (<span class="authorship-author-name">Gede Noémi</span> <span class="authorAux-mtmt"> Egészségtudomány</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Központi Szervezeti Egységek (beleértve az Egyéb Szervezeti Egységeket)">KSZE</span>/Transzlációs Medicina Központ</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10001298"><a href="/gui2/?type=authors&mode=browse&sel=10001298" target="_blank">Molnár Zsolt (<span class="authorship-author-name">Molnár Zsolt</span> <span class="authorAux-mtmt"> Klinikai orvostudományok - aneszteziológia és i...</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Központi Szervezeti Egységek (beleértve az Egyéb Szervezeti Egységeket)">KSZE</span>/Transzlációs Medicina Központ; <span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Klinikum">K</span>/Aneszteziológiai és Intenzív Terápiás Tanszék</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10015391"><a href="/gui2/?type=authors&mode=browse&sel=10015391" target="_blank">Duray Gábor (<span class="authorship-author-name">Duray Gábor Zoltán</span> <span class="authorAux-mtmt"> Kardiológia</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Központi Szervezeti Egységek (beleértve az Egyéb Szervezeti Egységeket)">KSZE</span>/Transzlációs Medicina Központ; <span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Klinikum">K</span>/Városmajori Szív- és Érgyógyászati Klinika</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10077662"><a href="/gui2/?type=authors&mode=browse&sel=10077662" target="_blank">Turan Caner (<span class="authorship-author-name">Turan Caner</span> <span class="authorAux-mtmt"> Anesthesia and Intensive Care</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Klinikum">K</span>/Aneszteziológiai és Intenzív Terápiás Klinika; <span title="Semmelweis Egyetem">SE</span>/<span title="Központi Szervezeti Egységek (beleértve az Egyéb Szervezeti Egységeket)">KSZE</span>/Transzlációs Medicina Központ</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10002629"><a href="/gui2/?type=authors&mode=browse&sel=10002629" target="_blank">Hegyi Péter (<span class="authorship-author-name">Hegyi Péter</span> <span class="authorAux-mtmt"> Gasztroenterológia</span>) </a> </span> <span class="author-affil"><span title="Pécsi Tudományegyetem">PTE</span>/<span title="Általános Orvostudományi Kar">ÁOK</span>/Transzlációs Medicina Intézet; <span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Klinikum">K</span>/Pankreász Betegségek Intézete; <span title="Semmelweis Egyetem">SE</span>/<span title="Központi Szervezeti Egységek (beleértve az Egyéb Szervezeti Egységeket)">KSZE</span>/Transzlációs Medicina Központ</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10011777"><a href="/gui2/?type=authors&mode=browse&sel=10011777" target="_blank">Horváth Gábor (<span class="authorship-author-name">Horváth Gábor</span> <span class="authorAux-mtmt"> Pulmonológia</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Klinikum">K</span>/Pulmonológiai Klinika</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10012282"><a href="/gui2/?type=authors&mode=browse&sel=10012282" target="_blank">Müller Veronika ✉ (<span class="authorship-author-name">Müller Veronika</span> <span class="authorAux-mtmt"> Pulmonológia</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Klinikum">K</span>/Pulmonológiai Klinika</span> </div> </div> <div class="title"><a href="/gui2/?mode=browse&params=publication;35635297" target="_blank">Treatable traits in idiopathic pulmonary fibrosis: focus on respiratory tract infections—a systematic review and a meta-analysis</a></div> <div> <span class="journal-title">ECLINICALMEDICINE</span> <span class="journal-issn">(<a target="_blank" href="https://portal.issn.org/resource/ISSN/2589-5370">2589-5370</a> <a target="_blank" href="https://portal.issn.org/resource/ISSN/2589-5370">2589-5370</a>)</span>: <span class="journal-volume">79</span> <span class="page"> Paper 102966. 12 p. </span> <span class="year">(2025)</span> </div> <div class="pub-footer"> <span class="language" xmlns="http://www.w3.org/1999/html">Nyelv: Angol | </span> <span class="identifiers"> <span class="id identifier oa_GOLD" title=" Gold "> <a style="color:blue" title="10.1016/j.eclinm.2024.102966" target="_blank" href="https://doi.org/10.1016/j.eclinm.2024.102966"> DOI </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="001373919000001" target="_blank" href="https://www.webofscience.com/wos/woscc/full-record/001373919000001"> WoS </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="85211017818" target="_blank" href="http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85211017818"> Scopus </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="39720602" target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=39720602&dopt=Abstract"> PubMed </a> </span> </span> <OnlyViewableByAuthor><div class="ratings"> <div class="journal-subject">Folyóirat szakterülete: Scopus - Medicine (miscellaneous)&nbsp;&nbsp;&nbsp;SJR indikátor:&nbsp;D1</div> </div></OnlyViewableByAuthor> <div class="publication-citation" style="margin-left: 0.5cm;"> <span title="Nyilvános idézőközlemények összesen, említések nélkül" class="citingPub-count">Nyilvános idéző összesen: 5</span> | Független: 5 | Függő: 0 | Nem jelölt: 0 | WoS jelölt: 4 | Scopus jelölt:&nbsp;5 | WoS/Scopus jelölt:&nbsp;5 | DOI jelölt:&nbsp;5 </div> <div class="publication-citation"> <a target="_blank" href="/api/publication?cond=citations.related;eq;35635297&sort=publishedYear,desc&sort=title"> Idézett közlemények száma: 8 </a> </div> <div class="mtid"><span class="long-pub-mtid">Közlemény: 35635297</span> | <span class="status-data status-APPROVED"> Nyilvános </span> Forrás Idéző | <span class="type-subtype">Folyóiratcikk ( Összefoglaló cikk ) </span> | <span class="pub-category">Tudományos</span> | <span class="publication-sourceOfData">kézi felvitel</span> </div> <div class="lastModified">Utolsó módosítás: 2026.05.29. 12:19 Siba Noémi (SE_ÁOK_ITK_Admin5_SN, admin) </div> <pre class="comment" style="margin-top: 0; margin-bottom: 0;"><u>Megjegyzés</u>: Department of Pulmonology, Semmelweis University, Budapest, Hungary Centre for Translational Medicine, Semmelweis University, Budapest, Hungary Department of Anesthesiology and Intensive Therapy, Semmelweis University, Budapest, Hungary Department of Anesthesiology and Intensive Therapy, Poznan University of Medical Science...</pre> </div></div>